$0.0886
At close: Jul 29, 8:35 AM EDT
$0.1000
0.0112.87%
After Hours: Jul 29, 8:35 AM EDT
Comments
Loading...
Estrella Immunopharma Analyst Ratings and Price Targets | NASDAQ:ESLAW | Benzinga
Estrella Immunopharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Estrella Immunopharma Corp from these most-recent analyst ratings.
Analyst Ratings for Estrella Immunopharma
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Estrella Immunopharma (ESLAW) stock?
There is no price target for Estrella Immunopharma
What is the most recent analyst rating for Estrella Immunopharma (ESLAW)?
There is no analyst for Estrella Immunopharma
When was the last upgrade for Estrella Immunopharma (ESLAW)?
There is no last upgrade for Estrella Immunopharma
When was the last downgrade for Estrella Immunopharma (ESLAW)?
There is no last downgrade for Estrella Immunopharma.
When is the next analyst rating going to be posted or updated for Estrella Immunopharma (ESLAW)?
There is no next analyst rating for Estrella Immunopharma.
Is the Analyst Rating Estrella Immunopharma (ESLAW) correct?
There is no next analyst rating for Estrella Immunopharma.
Browse analyst ratings and price targets on all stocks.